Sign in
Active, not recruitingNo phase

Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation

Key facts

Who runs it
Abbott Medical Devices
Where
Austria, Belgium, Czechia, France, Germany, Israel, Italy, Netherlands, Norway, Saudi Arabia, Spain, Switzerland, and United Kingdom36 sites in 13 countriesChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
200 people, planned
Started
4 May 2021
Expected to end
31 May 2028
Type of study
Observational
Treatments tested
  • Tendyne™ Mitral Valve System
Record updated
28 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Patient is indicated for the Tendyne Mitral Valve System per the Instructions for Use
  • Patient is willing and able to comply with all follow-up requirements through five years, including study-required testing, medications, and attending all follow-up visits
  • Patient provides written informed consent prior to any study-specific procedure

Who cannot take part

  • Patient has other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, may limit the subject's ability to participate in the clinical study or to comply with follow-up requirements
  • Patient is under the age of 18 or age of legal consent
  • Patient is in another clinical study that may impact the follow-up or results of this study
  • Patient is pregnant or nursing or plan to become pregnant during the study follow-up period

This trial has no sites in United States.

It has sites in 13 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

To evaluate the safety and performance of the Tendyne™ Mitral Valve System when used as intended in a contemporary, real-world setting.

Treatments tested

  • Tendyne™ Mitral Valve System

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation (RESOLVE-MR) (Tendyne™ PMCF Study)
Record updated
28 May 2026